RxDoctor Payments Data

Brittany Canady

Family · Whiteville, NCNPI 1336677699

Payments from drug & device makers

$1,036in general payments, 2019–2025

Across 59 payments — averaging $17.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$304
  • AstraZeneca$198
  • AbbVie$142
  • Astellas Pharma US Inc$69
  • Bayer$67
  • Lilly USA, LLC$52
  • plus $204 from 8 others

What the payments were for

  • Food & beverage$1,036100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,036 in reported general payments places this provider in the 70th percentile of 4,522 family providers in North Carolina.

See all family providers in North Carolina

Medicare billing

Part B allowed, 2024
$20,866
Medicare patients
72
Services billed
410

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide55$67,434
Breztri AerosphereBudesonide/Glycopyr/Formoterol25$25,139
FarxigaDapagliflozin Propanediol30$23,153
CaplytaLumateperone Tosylate11$17,511
OzempicSemaglutide14$13,152
Nurtec OdtRimegepant Sulfate11$11,052
JanuviaSitagliptin Phosphate15$8,623
Trelegy ElliptaFluticasone/Umeclidin/Vilanter13$8,451
EliquisApixaban12$7,910
LinzessLinaclotide13$7,077
Clorazepate Dipotassium12$1,840
Albuterol Sulfate HfaAlbuterol Sulfate47$1,418
SynthroidLevothyroxine Sodium16$1,218
Gabapentin84$995
Levothyroxine Sodium110$850

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro$52$67,43455 claims
AstraZenecaBreztri Aerosphere, Farxiga$198$48,29255 claims
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta$17$17,51111 claims
Novo NordiskOzempic$304$13,15214 claims
AbbVieLinzess, Synthroid$142$8,29529 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 4,522 family providers in North Carolina.

Other family in Whiteville

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →